Nature Clinical Practice Nephrology

- http://www.nature.com/ncpneph
- Editor: Robert W. Schrier
- Volume 4: 12 issues per year
- ISSN: 1745-8323
- EISSN: 1745-8331
- Impact factor : 4.764*
- Impact ranking: 5/55 in Urology and Nephrology*
- Date Established: November 2005
- Published on behalf of: An official publication of the International Society of Nephrology
An official publication of the International Society of Nephrology
Aims and Scope:
Nature Clinical Practice Nephrology
is a new peer-reviewed journal for nephrologists and affiliated healthcare workers.
Nature Clinical Practice Nephrology delivers timely interpretations of key developments reported in the original research, translating the latest findings into clinical practice.
Coverage includes all areas concerned with prevention, diagnosis, and treatment of disorders of the kidney in the adult and child, including hypertension, infection/inflammation, dialysis/chronic uremia, renal failure, transplantation, applied physiology, epidemiology, pathology, immunology, cancer, and genetics. Content is subject to rigorous peer review.
Nature Clinical Practice Nephrology is published monthly in print and online. Content includes editorial and opinion pieces, highlights from the current literature, commentaries on the application of recent research to practical patient care, comprehensive reviews, and in-depth case studies.
Readership:
Nephrologists and other physicians with interests in adult and pediatric
disorders of the kidney, including specialists in general internal medicine.
Staff and students at academic and teaching hospitals. Commercial and
government organizations involved in drug development and clinical trials.
Organized into sections, content includes:
- Editorials - thoughts from the Editor-in-Chief or his nominee.
- Viewpoints - opinion articles by leading specialists, discussing topical issues in the field.
- Research Highlights - brief summaries of important articles published in the original research journals, from the specialty-specific journals to journals in other areas that may include articles with surprising relevance to the Nature Clinical Practice journal's field of coverage.
- Practice Points - unique two-page articles based on original material published elsewhere. Each Practice Point is based on a single original research paper and includes a synopsis written by our editorial team along with a commentary by a leading authority, which puts the original article into clinical context and offers expert opinion on best practice.
- Reviews - timely, authoritative reviews of key developments, written by leading specialists. In addition to general reviews, these include the following:
- Therapy Insights - leading authorities from other specialties discuss conditions and therapies that have particular relevance to the Nature Clinical Practice journal's field of coverage.
- Drug Insights - review the information physicians and trainees need to know about a drug class.
- Mechanisms of Disease - discuss the etiology of disease.
- Technology Insights - focus on advances in treatment and diagnostic technologies and equipment, such as imaging techniques and technology-assisted surgery.
- Primer Articles - provide straightforward explanations of elements essential to understanding and evaluating original clinical research. Jargon-free and aimed at non-trialists, these foundation articles cover subjects such as statistical methods and good clinical practice.
- Case Studies - fully detailed descriptions of the etiology, diagnosis, and management of individual cases.
- Continuing Medical Education - the opportunity for physicians to earn Category 1 AMA PRA credits at no additional cost.
What makes Nature Clinical Practice stand apart from other clinical review journals?
- The Nature standards of editorial excellence are applied to the series as expected by readers, authors and institutional customers.
- World-renowned experts and opinion leaders are appointed as Editors-in-Chief to ensure content focuses on the key issues in the discipline.
- A distinguished international Advisory Board ensures accurate global coverage of the specialty and related subspecialties.
- Results-focused content provides physicians with the results of clinical trials and explains their application in practice, as opposed to lengthy research details.
- Online archive available back to November 2005.
- A site license provides access to all content published during the supply period. Access is granted to a further rolling four-year archive during the supply period only. Archive content not included in the license agreement is available to purchase.
- Users have access to all the online features of nature.com. Find out more >>
- Site license customers will benefit from the services available Find out more >>
- Indexed in Chemical Abstracts Service (CAS), Cumulative Index to Nursing and Allied Health Literature (CINAHL), Current Contents (Clinical Medicine), EMBASE, PubMed (MEDLINE) and Science Citation Index Expanded.
Editor-in-Chief: Robert W. Schrier, MD University of Colorado School of Medicine
Dr. Schrier has been President of the Association of American Physicians, the American Society of Nephrology, the National Kidney Foundation, and the International Society of Nephrology. Dr. Schrier is a Master of the American College of Physicians and an Honorary Fellow of the Royal College of Physicians. He is the author of more than 800 scientific papers and the editor of Diseases of the Kidney and Urinary Tract, Renal and Electrolyte Disorders, Manual of Nephrology and Essential Atlas of Nephrology and Hypertension. Dr. Schrier's research centers on the pathogenesis of acute renal failure, genetic renal disorders, mechanisms of renal cell injury, diabetic nephropathy, and renal and hormonal control of body fluid volume in cirrhosis, cardiac failure, nephrotic syndrome, and pregnancy. He brings to his research a unique combination of expertise in body fluid control mechanisms, renal function, and cardiovascular function. He has advanced a unifying hypothesis of sodium and water regulation in health and disease, stimulating worldwide interest in the biomedical science community. Dr. Schrier's research has been funded by the National Institutes of Health for the past 35 years. Advisory Board >>
Online features and site license access:
*2007 Journal Citation Report (Thomson Reuters, 2008)

